BRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf

9
3
Favorite

BRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf

Reuters2022-01-10

Jan 10 (Reuters) - Novavax Inc :

* NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN Q2- JPM CONF

* NOVAVAX EXEC SAYS DELIVERED 10 MILLION DOSES TO INDONESIA AND WILL DELIVER ANOTHER 40 MILLION DOSES OVER THE COMING QUARTERS- JPM CONF

* NOVAVAX EXEC SAYS BEGAN SHIPPING DOSES INTO OUR EUROPEAN DISTRIBUTION HUB- JPM CONF

* NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF

* NOVAVAX EXEC SAYS COMPANY IS WELL-PREPARED WITH A SOLID EUA APPLICATION FOR COVID-19 VACCINE, EXPECT A RESPONSE FROM U.S. FDA IN FEBRUARY- JPM CONF

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（3）

Frosty4ever
·2022-01-12
Delay month by month. Hope this is the final delay.
Reply
1
Report
Gaga71
·2022-01-11
Great!
Reply
7
Report
AhBart
·2022-01-11
Well done and good work 🤟🏼
Reply
3
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2202276939?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-01-10 22:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2202276939","market":"us","top_or_hot":-1,"title":"BRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf","media":"Reuters","content":"<html><body><p>Jan 10 (Reuters) - Novavax Inc   :</p><p>   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN Q2- JPM CONF</p><p>   * NOVAVAX EXEC SAYS DELIVERED 10 MILLION DOSES TO INDONESIA AND WILL DELIVER ANOTHER 40 MILLION DOSES OVER THE COMING QUARTERS- JPM CONF</p><p>   * NOVAVAX EXEC SAYS BEGAN SHIPPING DOSES INTO OUR EUROPEAN DISTRIBUTION HUB- JPM CONF</p><p>   * NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF</p><p>   * NOVAVAX EXEC SAYS COMPANY IS WELL-PREPARED WITH A SOLID EUA APPLICATION FOR COVID-19 VACCINE, EXPECT A RESPONSE FROM U.S. FDA IN FEBRUARY- JPM CONF</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-10 22:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Jan 10 (Reuters) - Novavax Inc   :   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVAX","symbol_name":"诺瓦瓦克斯医药","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2202276939","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2202276939","pubTimestamp":1641825736,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Jan 10 (Reuters) - Novavax Inc   :   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BK4139":"生物科技","BK4568":"美国抗疫概念"},"translate_title":"简报-诺瓦瓦克斯医药表示，新冠肺炎疫苗的EUA申请准备充分，预计美国食品和药物管理局将在2月份做出回应-JPM Conf","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":0.9},"content_text":"Jan 10 (Reuters) - Novavax Inc   :   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN Q2- JPM CONF   * NOVAVAX EXEC SAYS DELIVERED 10 MILLION DOSES TO INDONESIA AND WILL DELIVER ANOTHER 40 MILLION DOSES OVER THE COMING QUARTERS- JPM CONF   * NOVAVAX EXEC SAYS BEGAN SHIPPING DOSES INTO OUR EUROPEAN DISTRIBUTION HUB- JPM CONF   * NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF   * NOVAVAX EXEC SAYS COMPANY IS WELL-PREPARED WITH A SOLID EUA APPLICATION FOR COVID-19 VACCINE, EXPECT A RESPONSE FROM U.S. FDA IN FEBRUARY- JPM CONFSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9002164537,"gmtCreate":1641947331109,"gmtModify":1676533664862,"author":{"id":"3583106134648492","authorId":"3583106134648492","name":"Frosty4ever","avatar":"https://community-static.tradeup.com/news/58fdf90023b13bdabb45b46bb0d645e1","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":3,"crmLevelSwitch":1,"idStr":"3583106134648492","authorIdStr":"3583106134648492"},"htmlText":"Delay month by month. Hope this is the final delay.&nbsp;","listText":"Delay month by month. Hope this is the final delay.&nbsp;","text":"Delay month by month. Hope this is the final delay.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002164537","repostId":2202276939,"repostType":2,"repost":{"id":"2202276939","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641825736,"share":"https://ttm.financial/m/news/2202276939?lang=&edition=fundamental","pubTime":"2022-01-10 22:42","market":"us","language":"en","title":"BRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf","url":"https://stock-news.laohu8.com/highlight/detail?id=2202276939","media":"Reuters","summary":"Jan 10 (Reuters) - Novavax Inc   :   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 ","content":"<html><body><p>Jan 10 (Reuters) - Novavax Inc   :</p><p>   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN Q2- JPM CONF</p><p>   * NOVAVAX EXEC SAYS DELIVERED 10 MILLION DOSES TO INDONESIA AND WILL DELIVER ANOTHER 40 MILLION DOSES OVER THE COMING QUARTERS- JPM CONF</p><p>   * NOVAVAX EXEC SAYS BEGAN SHIPPING DOSES INTO OUR EUROPEAN DISTRIBUTION HUB- JPM CONF</p><p>   * NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF</p><p>   * NOVAVAX EXEC SAYS COMPANY IS WELL-PREPARED WITH A SOLID EUA APPLICATION FOR COVID-19 VACCINE, EXPECT A RESPONSE FROM U.S. FDA IN FEBRUARY- JPM CONF</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-10 22:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Jan 10 (Reuters) - Novavax Inc   :</p><p>   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN Q2- JPM CONF</p><p>   * NOVAVAX EXEC SAYS DELIVERED 10 MILLION DOSES TO INDONESIA AND WILL DELIVER ANOTHER 40 MILLION DOSES OVER THE COMING QUARTERS- JPM CONF</p><p>   * NOVAVAX EXEC SAYS BEGAN SHIPPING DOSES INTO OUR EUROPEAN DISTRIBUTION HUB- JPM CONF</p><p>   * NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF</p><p>   * NOVAVAX EXEC SAYS COMPANY IS WELL-PREPARED WITH A SOLID EUA APPLICATION FOR COVID-19 VACCINE, EXPECT A RESPONSE FROM U.S. FDA IN FEBRUARY- JPM CONF</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技","BK4568":"美国抗疫概念","NVAX":"诺瓦瓦克斯医药"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2202276939","content_text":"Jan 10 (Reuters) - Novavax Inc   :   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN Q2- JPM CONF   * NOVAVAX EXEC SAYS DELIVERED 10 MILLION DOSES TO INDONESIA AND WILL DELIVER ANOTHER 40 MILLION DOSES OVER THE COMING QUARTERS- JPM CONF   * NOVAVAX EXEC SAYS BEGAN SHIPPING DOSES INTO OUR EUROPEAN DISTRIBUTION HUB- JPM CONF   * NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF   * NOVAVAX EXEC SAYS COMPANY IS WELL-PREPARED WITH A SOLID EUA APPLICATION FOR COVID-19 VACCINE, EXPECT A RESPONSE FROM U.S. FDA IN FEBRUARY- JPM CONFSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002064843,"gmtCreate":1641864782763,"gmtModify":1676533656586,"author":{"id":"3579082097230100","authorId":"3579082097230100","name":"Gaga71","avatar":"https://static.tigerbbs.com/02afa88b95dc30f4a60767c18f9e2f39","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3579082097230100","authorIdStr":"3579082097230100"},"htmlText":"Great!&nbsp;","listText":"Great!&nbsp;","text":"Great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002064843","repostId":2202276939,"repostType":2,"repost":{"id":"2202276939","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641825736,"share":"https://ttm.financial/m/news/2202276939?lang=&edition=fundamental","pubTime":"2022-01-10 22:42","market":"us","language":"en","title":"BRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf","url":"https://stock-news.laohu8.com/highlight/detail?id=2202276939","media":"Reuters","summary":"Jan 10 (Reuters) - Novavax Inc   :   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 ","content":"<html><body><p>Jan 10 (Reuters) - Novavax Inc   :</p><p>   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN Q2- JPM CONF</p><p>   * NOVAVAX EXEC SAYS DELIVERED 10 MILLION DOSES TO INDONESIA AND WILL DELIVER ANOTHER 40 MILLION DOSES OVER THE COMING QUARTERS- JPM CONF</p><p>   * NOVAVAX EXEC SAYS BEGAN SHIPPING DOSES INTO OUR EUROPEAN DISTRIBUTION HUB- JPM CONF</p><p>   * NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF</p><p>   * NOVAVAX EXEC SAYS COMPANY IS WELL-PREPARED WITH A SOLID EUA APPLICATION FOR COVID-19 VACCINE, EXPECT A RESPONSE FROM U.S. FDA IN FEBRUARY- JPM CONF</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-10 22:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Jan 10 (Reuters) - Novavax Inc   :</p><p>   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN Q2- JPM CONF</p><p>   * NOVAVAX EXEC SAYS DELIVERED 10 MILLION DOSES TO INDONESIA AND WILL DELIVER ANOTHER 40 MILLION DOSES OVER THE COMING QUARTERS- JPM CONF</p><p>   * NOVAVAX EXEC SAYS BEGAN SHIPPING DOSES INTO OUR EUROPEAN DISTRIBUTION HUB- JPM CONF</p><p>   * NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF</p><p>   * NOVAVAX EXEC SAYS COMPANY IS WELL-PREPARED WITH A SOLID EUA APPLICATION FOR COVID-19 VACCINE, EXPECT A RESPONSE FROM U.S. FDA IN FEBRUARY- JPM CONF</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技","BK4568":"美国抗疫概念","NVAX":"诺瓦瓦克斯医药"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2202276939","content_text":"Jan 10 (Reuters) - Novavax Inc   :   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN Q2- JPM CONF   * NOVAVAX EXEC SAYS DELIVERED 10 MILLION DOSES TO INDONESIA AND WILL DELIVER ANOTHER 40 MILLION DOSES OVER THE COMING QUARTERS- JPM CONF   * NOVAVAX EXEC SAYS BEGAN SHIPPING DOSES INTO OUR EUROPEAN DISTRIBUTION HUB- JPM CONF   * NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF   * NOVAVAX EXEC SAYS COMPANY IS WELL-PREPARED WITH A SOLID EUA APPLICATION FOR COVID-19 VACCINE, EXPECT A RESPONSE FROM U.S. FDA IN FEBRUARY- JPM CONFSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9006790248,"gmtCreate":1641831041501,"gmtModify":1676533652315,"author":{"id":"4099263395755910","authorId":"4099263395755910","name":"AhBart","avatar":"https://static.itradeup.com/news/5c8a0140b30f2d6c3be37b2ad1a1efe8","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"4099263395755910","authorIdStr":"4099263395755910"},"htmlText":"Well done and good work 🤟🏼","listText":"Well done and good work 🤟🏼","text":"Well done and good work 🤟🏼","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006790248","repostId":2202276939,"repostType":2,"repost":{"id":"2202276939","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641825736,"share":"https://ttm.financial/m/news/2202276939?lang=&edition=fundamental","pubTime":"2022-01-10 22:42","market":"us","language":"en","title":"BRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf","url":"https://stock-news.laohu8.com/highlight/detail?id=2202276939","media":"Reuters","summary":"Jan 10 (Reuters) - Novavax Inc   :   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 ","content":"<html><body><p>Jan 10 (Reuters) - Novavax Inc   :</p><p>   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN Q2- JPM CONF</p><p>   * NOVAVAX EXEC SAYS DELIVERED 10 MILLION DOSES TO INDONESIA AND WILL DELIVER ANOTHER 40 MILLION DOSES OVER THE COMING QUARTERS- JPM CONF</p><p>   * NOVAVAX EXEC SAYS BEGAN SHIPPING DOSES INTO OUR EUROPEAN DISTRIBUTION HUB- JPM CONF</p><p>   * NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF</p><p>   * NOVAVAX EXEC SAYS COMPANY IS WELL-PREPARED WITH A SOLID EUA APPLICATION FOR COVID-19 VACCINE, EXPECT A RESPONSE FROM U.S. FDA IN FEBRUARY- JPM CONF</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-10 22:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Jan 10 (Reuters) - Novavax Inc   :</p><p>   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN Q2- JPM CONF</p><p>   * NOVAVAX EXEC SAYS DELIVERED 10 MILLION DOSES TO INDONESIA AND WILL DELIVER ANOTHER 40 MILLION DOSES OVER THE COMING QUARTERS- JPM CONF</p><p>   * NOVAVAX EXEC SAYS BEGAN SHIPPING DOSES INTO OUR EUROPEAN DISTRIBUTION HUB- JPM CONF</p><p>   * NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF</p><p>   * NOVAVAX EXEC SAYS COMPANY IS WELL-PREPARED WITH A SOLID EUA APPLICATION FOR COVID-19 VACCINE, EXPECT A RESPONSE FROM U.S. FDA IN FEBRUARY- JPM CONF</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技","BK4568":"美国抗疫概念","NVAX":"诺瓦瓦克斯医药"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2202276939","content_text":"Jan 10 (Reuters) - Novavax Inc   :   * NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN Q2- JPM CONF   * NOVAVAX EXEC SAYS DELIVERED 10 MILLION DOSES TO INDONESIA AND WILL DELIVER ANOTHER 40 MILLION DOSES OVER THE COMING QUARTERS- JPM CONF   * NOVAVAX EXEC SAYS BEGAN SHIPPING DOSES INTO OUR EUROPEAN DISTRIBUTION HUB- JPM CONF   * NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF   * NOVAVAX EXEC SAYS COMPANY IS WELL-PREPARED WITH A SOLID EUA APPLICATION FOR COVID-19 VACCINE, EXPECT A RESPONSE FROM U.S. FDA IN FEBRUARY- JPM CONFSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":9,"commentSize":3,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}